Nuclear Watchdog Sets Up Board for Mysterious NuFuels Drama
Published Date: 8/6/2026
Notice
Summary
No summary available.
No Economic Impacts Identified for this Document
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-13687, Implementation of the National Environmental Policy Act
The Nuclear Regulatory Commission is updating how it follows the National Environmental Policy Act to make reviews faster, clearer, and less of a hassle. These changes affect anyone applying for nuclear licenses or permits, cutting down on paperwork and focusing only on important environmental impacts. You’ve got until August 21, 2026, to share your thoughts before the new rules take shape!
2026-12067, Fee Schedules; Fee Recovery for Fiscal Year 2026
The Nuclear Regulatory Commission is updating its fees for licenses, inspections, and special projects starting August 17, 2026. These changes make sure the NRC covers nearly all its costs while setting clear fee limits to keep prices predictable and fair. If you hold a license or apply for one, expect some fee adjustments that help the NRC run smoothly and efficiently.
2026-08015, Generic Environmental Impact Statement for Licensing of New Nuclear Reactors
The Nuclear Regulatory Commission just updated the rules for checking the environmental impact of new nuclear reactors. This makes it easier and faster to review many reactors by using a common set of environmental factors, while still looking closely at unique site details. The new rules kick in on May 26, 2026, helping companies save time and money when applying to build new reactors.
2026-06048, Risk-Informed, Technology-Inclusive Regulatory Framework for Advanced Reactors
The Nuclear Regulatory Commission is updating its rules to make it easier and faster to approve new types of nuclear reactors, not just the old light-water ones. This change helps companies building advanced reactors by using smarter, risk-based rules that fit new technology. The new rules start on April 29, 2026, and could save time and money for the nuclear industry and the public.
2026-04823, Fee Schedules; Fee Recovery for Fiscal Year 2026
The Nuclear Regulatory Commission (NRC) is updating its fees for licenses, inspections, and special projects for fiscal year 2026. These changes aim to cover nearly all NRC costs and set fixed fee limits to boost efficiency and fairness. If you’re involved with the NRC, get ready for new fees by September 30, 2026, and don’t miss the April 13 deadline to share your thoughts!
2025-14147, Fee Schedules; Fee Recovery for Fiscal Year 2025
The U.S. Nuclear Regulatory Commission fixed a typo in their fee schedule for 2025. This update affects companies and government agencies that pay licensing and inspection fees, making sure the right amounts are charged. The corrected fees kick in soon, so everyone can plan their budgets without surprises!
Previous / Next Documents
Previous: 2026-15961, Request for Public Comments on the Proposed Implementation of Duties on Additional Aluminum, Steel, and Copper Derivative Articles Under Section 232
This notice requests public comments on a proposal to include 14 additional derivative articles within the scope of the Section 232 duties on steel, aluminum, and copper: aluminum powder; brass-wind musical instruments and their parts and accessories; parts of welding machines and apparatus; floor safes; certain electric conductor cables; fire extinguishers; parts of heat exchange units; parts of certain hydraulic engines and motors; certain self-propelled cranes, mobile lifting frames, and straddle carriers; tanker trailers and semi- trailers; self-loading or self-unloading trailers and semi-trailers for agricultural purposes; certain other trailers and semi-trailers; and certain filled steel containers.
Next: 2026-15964, Authorization of Emergency Use of an In Vitro Diagnostic Device in Response to an Outbreak of Mpox; Availability
The Food and Drug Administration (FDA or Agency) is announcing the issuance of an Emergency Use Authorization (EUA) (the Authorization) under the Federal Food, Drug, and Cosmetic Act (FD&C Act) in response to an outbreak of Mpox. FDA has issued an Authorization for an in vitro diagnostic device, Allplex HSV-1&2/VZV/ MPXV Assay, for the simultaneous qualitative detection and differentiation of viral nucleic acid from monkeypox virus (MPXV clade I/II and MPXV clade II)1, herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2), and varicella-zoster virus (VZV). The Authorization contains, among other things, conditions on the emergency use of the authorized product. The Authorization follows the August 9, 2022, determination by the Secretary of Health and Human Services (HHS) that there is a public health emergency, or a significant potential for a public health emergency, that affects, or has a significant potential to affect, national security or the health and security of U.S. citizens living abroad, and that involves monkeypox virus. On the basis of such determination, the Secretary of HHS declared, on September 7, 2022, that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of infection with the monkeypox virus, including in vitro diagnostics that detect and/or diagnose infection with non-variola Orthopoxvirus, pursuant to the FD&C Act, subject to terms of any authorization issued under that section. The Authorization, which includes an explanation of the reasons for issuance, is listed in this document, and can be accessed on FDA's website from the link indicated.